A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2006
10/17/2006	US7122530 24-hydroxyvitamin D, analogs and uses thereof
10/17/2006	US7122528 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
10/17/2006	US7122525 Targeted therapeutics and uses thereof
10/17/2006	US7122518 Administering a quenching photosensitizer molecule for side effect reduction to retinal pigmented epithelium; age related macular degeneration
10/17/2006	US7122517 Crystallized structure of type IV collagen NC1 domain hexamer
10/17/2006	US7122514 Coadministration of a lysostaphin or other antistaphylococcal agent which cleaves glycine crosslinks of the peptidoglycans of staphylococci cell walls and an antibiotic effective due to the cell wall activity, e.g., beta lactams and glycopeptides
10/17/2006	US7122362 For diagnosing, treating, or preventing disorders associated with aberrant expression of human phosphodiesterases
10/17/2006	US7122344 Production of recombinant human uteroglobin (rhUG) for use as a therapeutic in the treatment of inflammation and fibrotic diseases. The invention provides processes, including bacterial expression and protein purification and scaled
10/17/2006	US7122336 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
10/17/2006	US7122327 Utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state, and most particularly to specific biopolymer markers whose up-regulation, down-regulation, or relative presence in disease vs. normal states
10/17/2006	US7122326 Central nervous system disorders; psychological disorders
10/17/2006	US7122191 Microfluidized oil-in-water emulsions and vaccine compositions
10/17/2006	US7122183 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of CD30 or CD30L
10/17/2006	US7122173 A compound having slowly-deactivating A-type K+ channel opening activity such as N-(5,5-dioxido-10-oxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide
10/17/2006	CA2339661C Use of derivatives of aryl(or heteroaryl)azolylcarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p
10/17/2006	CA2322502C Protease inhibitors in absorbent articles
10/17/2006	CA2177179C Antagonists to chaperonin 10
10/17/2006	CA2166530C Stimulation of tanning by dna fragments or single-stranded dna
10/12/2006	WO2006108055A1 Glutamate modulating agents in the treatment of mental disorders
10/12/2006	WO2006107528A1 Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
10/12/2006	WO2006107097A1 Nasal vaccine
10/12/2006	WO2006107027A1 Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia
10/12/2006	WO2006107019A1 Preventive or remedy for depression or anxiety neurosis
10/12/2006	WO2006106839A1 METHOD FOR SCREENING AUXILIARY AGENT CAPABLE OF PROMOTING THE INDUCTION OF INTERFERON-α AND/OR -β (IFN-α/β) EXPRESSION
10/12/2006	WO2006106599A1 Pharmaceutical for preventing and/or treating disease caused by abnormal enhancement of extracellular domain shedding
10/12/2006	WO2006105726A1 A composition for treating hypertension
10/12/2006	WO2006105670A1 Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
10/12/2006	WO2006034354A3 Methods of diagnosing and treating vhl associated tumors and sporadic renal cell carcinoma, other vhl sporadic counterpart tumors and non-tumor lesions which co-express epo and the epo receptor
10/12/2006	WO2005117954A3 Compositions and methods for treatment of neovascular diseases
10/12/2006	WO2005117854A3 Aryl ketone compounds and compositions for delivering active agents
10/12/2006	WO2005044792A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
10/12/2006	WO2005030132A3 Therapeutic regimens for administering drug combinations
10/12/2006	WO2005007149A8 Ambroxol for treating acute pains
10/12/2006	US20060230467 Plant deoxyribonucleoside kinase enzymes and their use
10/12/2006	US20060229588 Irrigation solution and method for inhibition of pain and inflammation
10/12/2006	US20060229360 Nontoxic potentiation/sensitization of cancer therapy by supplementary treatment with combined Vitamins C and K3
10/12/2006	US20060229356 Use of indomethacin and derivatives as broad-spectrum antiviral drugs and corresponding pharmaceutical compositions
10/12/2006	US20060229345 Compositions comprising epothilones and their use for the treatment of carcinoid syndrome
10/12/2006	US20060229340 Composition for improving cognition and memory
10/12/2006	US20060229339 Novel use of substituted aminomethyl chromans
10/12/2006	US20060229288 Adjust concentration of oocytes in cells of mammals ; stimulant of ovaries follicular growth
10/12/2006	US20060229262 Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant
10/12/2006	US20060229242 Composition comprising a pulmonary surfactant and a pde2 inhibitor
10/12/2006	US20060229239 Novel curcuminoid-factor VIIa constructs as suppressors of tumor growth and angiogenesis
10/12/2006	US20060228752 Genetic polymorphisms in the preprotachykinin gene
10/12/2006	US20060228745 Gene detection assay for improving the likelhood of an effective response to an ErbB antagonist cancer therapy
10/12/2006	US20060228407 Enhanced delivery via serpin enzyme complex receptor
10/12/2006	US20060228394 Ocular solutions
10/12/2006	US20060228393 Ocular solutions
10/12/2006	US20060228354 Modified ADAMTS4 molecules and method of use thereof
10/12/2006	US20060228353 PTH1R and PTH3R receptors, methods and uses thereof
10/12/2006	US20060228308 Oral health care drink and method for reducing malodors
10/12/2006	US20060228305 Pharmaceutical compositions based on anticholinergics and inhibitors of tnf alpha synthesis or action
10/12/2006	DE102005016345A1 Neue Verwendung von 2-Phenyl-substituierten Imidazotriazinon-Derivaten New use of 2-phenyl-substituted imidazotriazinone derivatives
10/12/2006	CA2604494A1 Improved method and apparatus for treating bacterial infections in devices
10/12/2006	CA2603926A1 Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain
10/12/2006	CA2601988A1 Prophylactic or therapeutic agent for noctural conduct disorder associated with dementia
10/11/2006	EP1710582A2 Suppressor genes
10/11/2006	EP1710257A1 Hyaluronic acid derivative and drug containing the same
10/11/2006	EP1709974A2 Method of treating cardiovascular disease using rapamycin
10/11/2006	EP1709973A1 Method of suppressing cancer
10/11/2006	EP1709037A2 Hiv protease inhibiting sulfonamides
10/11/2006	EP1708754A2 COMBINATIONS OF SEROTONIN REUPTAKE INHIBITORS AND IMIDAZOLINE-I sb 2 /sb -AGONISTS
10/11/2006	EP1708742A2 Methods of enhancing immune response in the intradermal compartment and compounds useful thereof
10/11/2006	EP1708739A1 Neuroprotective complex for treatment of cerebral ischemia and injury
10/11/2006	EP1708732A2 Synthetic hla binding peptide analogues and uses thereof
10/11/2006	EP1708729A1 Composition comprising an aqueous extract of red vine leaves and a diuretic for the treatment of chronic venous insufficiences
10/11/2006	EP1708728A1 Composition comprising an aqueous extract of red vine leaves and a antithrombotic agent for the treatment of chronic venous insufficiences
10/11/2006	EP1708727A1 Composition comprising an aqueous extract of red vine leaves and a blood circulation-improving agent for the treatment of chronic venous insufficiences
10/11/2006	EP1708725A1 Therapeutical composition for the treatment of dermatosis comprising an extract of calendula officinalis and hypericum perforatum
10/11/2006	EP1708722A1 Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
10/11/2006	EP1708719A2 Aqueous pharmaceutical compositions 2,6-diisopropylphenol (propofol) and their use
10/11/2006	EP1708714A1 Use of substituted pyrimido pyrimido 5,4-d¨pyrimidines in the treatment of diseases of the respiratory tract
10/11/2006	EP1708709A1 METHODS OF TREATING ACUTE INFLAMMATION IN ANIMALS WITH p38 MAP KINASE INHIBITORS
10/11/2006	EP1708691A1 Combination of organic compounds
10/11/2006	EP1708676A2 Methods and compositions for facilitating metabolic control
10/11/2006	EP1469851B1 Melanocortin receptor agonists
10/11/2006	EP1430045B1 Pyrane derivatives as both ace- and nep-inhibitors
10/11/2006	EP1384998B1 Eyestrain model, method of constructing the same, evaluation method with the use of the model and drugs screened by using the evaluation method
10/11/2006	EP1289511A4 Bactericidal preparation
10/11/2006	EP1276505B1 Mixtures of triblock polyesterpolyethylene glycol copolymers
10/11/2006	EP1257573B1 New transcription factor carp-2
10/11/2006	EP1250600B1 Diagnosis of tauopathies determining tau/phospho-tau ratio
10/11/2006	EP1226212B1 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof
10/11/2006	EP1181013B1 Method and composition for the treatment of cancer
10/11/2006	EP1147134B1 Novel potassium channels and genes encoding these potassium channels
10/11/2006	EP1133311B1 INFLUENCING ANGIOGENESIS USING CD66a
10/11/2006	EP1049465B1 Use of inhibitors for the treatment of disorders related to rtk hyperfunction, especially cancer
10/11/2006	EP0972041B1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor
10/11/2006	EP0954565B1 Adipogenic differentiation of human mesenchymal stem cells
10/11/2006	EP0914448B1 Lipid kinase
10/11/2006	EP0814803B1 Use of steroidal estrogen receptor antagonists as male contraceptives
10/11/2006	EP0751782B1 Use of a non-neutralizing antibody specific for the beta-subunit of luteinizing hormone for enhancing fertility
10/11/2006	CN1845920A 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
10/11/2006	CN1845911A Condensed ring compound and use thereof
10/11/2006	CN1845757A Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture
10/11/2006	CN1845747A Synergistic antimicrobial ophthalmic and dermatologic preparations
10/11/2006	CN1845746A Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents
10/11/2006	CN1845731A Combination therapy for glycaemic control
10/11/2006	CN1845729A Pharmaceutical composition comprising I.A. vitamin C, magnesium, green tea extract for retarding cardiovascular diseases

1 ... 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 ... 1151